2023 Q1 Form 10-K Financial Statement

#000157587223000493 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $20.21M $29.90M $95.25M
YoY Change 17.37% 21.18% 36.03%
Cost Of Revenue $16.66M $20.56M $70.04M
YoY Change 17.15% 5.78% 37.57%
Gross Profit $3.557M $9.343M $25.21M
YoY Change 18.45% 78.24% 31.9%
Gross Profit Margin 17.6% 31.25% 26.47%
Selling, General & Admin $15.09M $21.08M $66.19M
YoY Change -5.3% 20.27% 28.69%
% of Gross Profit 424.2% 225.67% 262.54%
Research & Development $3.528M $3.246M $11.30M
YoY Change 40.31% 35.74% 61.84%
% of Gross Profit 99.16% 34.75% 44.81%
Depreciation & Amortization $1.152M $1.059M $4.162M
YoY Change 23.41% 64.81% 126.32%
% of Gross Profit 32.39% 11.33% 16.51%
Operating Expenses $18.62M $24.33M $77.49M
YoY Change 0.92% 22.13% 32.65%
Operating Profit -$15.06M -$14.99M -$52.28M
YoY Change -2.49% 2.09% 33.01%
Interest Expense $6.785M -$7.621M $14.85M
YoY Change 87.64% 2664.86% 528.36%
% of Operating Profit
Other Income/Expense, Net $6.785M -$453.5K $12.98M
YoY Change -2566.18% -2306.71%
Pretax Income -$8.275M -$23.06M -$39.30M
YoY Change -31.63% 54.21% 4.72%
Income Tax
% Of Pretax Income
Net Earnings -$8.300M -$23.06M -$39.30M
YoY Change -31.43% 54.21% 4.73%
Net Earnings / Revenue -41.06% -77.13% -41.26%
Basic Earnings Per Share -$0.56 -$7.09
Diluted Earnings Per Share -$0.56 -$1.74 -$7.09
COMMON SHARES
Basic Shares Outstanding 14.95M 12.33M 6.591M
Diluted Shares Outstanding 14.72M 6.591M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.357M $2.564M $2.564M
YoY Change 151.62% -65.68% -65.68%
Cash & Equivalents $2.357M $2.564M
Short-Term Investments
Other Short-Term Assets $921.2K $369.8K $369.8K
YoY Change -14.34% -52.96% -52.96%
Inventory $32.66M $40.37M $40.37M
Prepaid Expenses $369.8K
Receivables $12.47M $16.81M $16.81M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $48.42M $60.11M $60.11M
YoY Change -17.12% -7.34% -7.34%
LONG-TERM ASSETS
Property, Plant & Equipment $18.56M $17.50M $21.92M
YoY Change 5.13% 31.17% 64.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.786M $1.891M $1.891M
YoY Change 99.17% 154.59% 154.59%
Total Long-Term Assets $25.49M $23.81M $23.81M
YoY Change 33.82% 69.03% 69.03%
TOTAL ASSETS
Total Short-Term Assets $48.42M $60.11M $60.11M
Total Long-Term Assets $25.49M $23.81M $23.81M
Total Assets $73.91M $83.92M $83.92M
YoY Change -4.59% 6.29% 6.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.98M $29.67M $29.67M
YoY Change 59.32% 105.47% 105.47%
Accrued Expenses $3.311M $3.011M $3.971M
YoY Change 32.69% 65.84% 118.69%
Deferred Revenue
YoY Change
Short-Term Debt $1.241M $973.6K $973.6K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $49.14M $50.73M $50.73M
YoY Change 73.75% 140.91% 140.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.225M $3.477M $3.477M
YoY Change 122.7%
Total Long-Term Liabilities $3.225M $3.477M $3.477M
YoY Change 122.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.14M $50.73M $50.73M
Total Long-Term Liabilities $3.225M $3.477M $3.477M
Total Liabilities $52.36M $54.21M $54.21M
YoY Change 76.14% 157.43% 157.43%
SHAREHOLDERS EQUITY
Retained Earnings -$153.2M -$145.0M
YoY Change 47.53%
Common Stock $1.495K $1.408K
YoY Change 1537.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.55M $29.71M $29.71M
YoY Change
Total Liabilities & Shareholders Equity $73.91M $83.92M $83.92M
YoY Change -4.59% 6.29% 6.29%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$8.300M -$23.06M -$39.30M
YoY Change -31.43% 54.21% 4.73%
Depreciation, Depletion And Amortization $1.152M $1.059M $4.162M
YoY Change 23.41% 64.81% 126.32%
Cash From Operating Activities $782.9K -$6.997M -$37.30M
YoY Change -107.78% -65.83% -43.64%
INVESTING ACTIVITIES
Capital Expenditures $1.258M -$2.014M $5.100M
YoY Change -272.68% -37.86% -145.13%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $50.00K
YoY Change -100.0%
Cash From Investing Activities -$1.258M $2.014M -$5.050M
YoY Change 85.41% -162.14% -55.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $32.98M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 267.7K 5.959M 37.43M
YoY Change -93.63% -54.77%
NET CHANGE
Cash From Operating Activities 782.9K -6.997M -37.30M
Cash From Investing Activities -1.258M 2.014M -5.050M
Cash From Financing Activities 267.7K 5.959M 37.43M
Net Change In Cash -207.0K 975.8K -4.908M
YoY Change -96.83% -104.11% -92.58%
FREE CASH FLOW
Cash From Operating Activities $782.9K -$6.997M -$37.30M
Capital Expenditures $1.258M -$2.014M $5.100M
Free Cash Flow -$474.7K -$4.983M -$42.40M
YoY Change -94.91% -71.09% -22.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001668370
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38739
CY2022 dei Entity Registrant Name
EntityRegistrantName
TOUGHBUILT INDUSTRIES, INC.
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0820877
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
8669 Research Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
CY2022 dei City Area Code
CityAreaCode
949
CY2022 dei Local Phone Number
LocalPhoneNumber
528-3100
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
31387992.59
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14946442
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
Costa Mesa, California
CY2022Q4 us-gaap Cash
Cash
2564237
CY2021Q4 us-gaap Cash
Cash
7472224
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16810659
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18179933
CY2022Q4 us-gaap Inventory Net
InventoryNet
40365286
CY2021Q4 us-gaap Inventory Net
InventoryNet
38432012
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
369792
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
786036
CY2022Q4 us-gaap Assets Current
AssetsCurrent
60109974
CY2021Q4 us-gaap Assets Current
AssetsCurrent
64870205
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17500383
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13341629
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4415859
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1890780
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
742691
CY2022Q4 us-gaap Assets
Assets
83916996
CY2021Q4 us-gaap Assets
Assets
78954525
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29671272
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14440506
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3010914
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1815567
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
959630
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
973583
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16116273
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4801929
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50731672
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21058002
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3477380
CY2022Q4 us-gaap Liabilities
Liabilities
54209052
CY2021Q4 us-gaap Liabilities
Liabilities
21058002
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14078997
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14078997
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
861997
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
861997
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1408
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
86
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
174659589
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156184327
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144953053
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98287890
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29707944
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57896523
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83916996
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78954525
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95253767
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70026324
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70042504
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50912513
CY2022 us-gaap Gross Profit
GrossProfit
25211263
CY2021 us-gaap Gross Profit
GrossProfit
19113811
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66189907
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51434180
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11296948
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6980453
CY2022 us-gaap Operating Expenses
OperatingExpenses
77486855
CY2021 us-gaap Operating Expenses
OperatingExpenses
58414633
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-52275592
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-39300822
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
1914120
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
297931
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16763205
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2661076
CY2022 tblt Warrant Issuance Costs
WarrantIssuanceCosts
1868766
CY2021 tblt Warrant Issuance Costs
WarrantIssuanceCosts
588221
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12980319
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1774924
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-39295273
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-37525898
CY2022 tblt Common Stock Deemed Dividend
CommonStockDeemedDividend
7467200
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46762473
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37525898
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.09
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.09
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-56.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-56.08
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6591356
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6591356
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
669125
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
669125
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19346053
CY2021 tblt Issuance Of Common Stock Upon Conversion Of Warrants
IssuanceOfCommonStockUponConversionOfWarrants
5412540
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
189000
CY2021 tblt Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
70229280
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
245548
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37525898
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57896523
CY2022 tblt Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
9154422
CY2022 tblt Adjustments To Additional Paid In Capital Preferred Stock Value
AdjustmentsToAdditionalPaidInCapitalPreferredStockValue
1833995
CY2022 tblt Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
9230014
CY2022 tblt Repurchase Of Common Stock Warrants
RepurchaseOfCommonStockWarrants
-2500000
CY2022 tblt Stock Issued During Period Value Adoption Of Lease Guidance
StockIssuedDuringPeriodValueAdoptionOfLeaseGuidance
97310
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
758152
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46762473
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29707944
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-39295273
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-37525898
CY2022 us-gaap Depreciation
Depreciation
4162153
CY2021 us-gaap Depreciation
Depreciation
1839069
CY2022 tblt Provision For Doubtful Accounts1
ProvisionForDoubtfulAccounts1
-2918869
CY2021 tblt Provision For Doubtful Accounts1
ProvisionForDoubtfulAccounts1
0
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
758152
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
245548
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15806
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
640059
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
713958
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
189000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16763205
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2661076
CY2022 tblt Loss On Exchange Transaction
LossOnExchangeTransaction
0
CY2021 tblt Loss On Exchange Transaction
LossOnExchangeTransaction
0
CY2022 tblt Warrant Issuance Costs
WarrantIssuanceCosts
1868766
CY2021 tblt Warrant Issuance Costs
WarrantIssuanceCosts
588221
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1549595
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7642538
CY2022 tblt Increase Decrease In Factor Receivables Net
IncreaseDecreaseInFactorReceivablesNet
0
CY2021 tblt Increase Decrease In Factor Receivables Net
IncreaseDecreaseInFactorReceivablesNet
807648
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1933274
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
29516668
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-416244
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
422323
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1148089
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
614969
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11943821
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6672358
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1302897
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1217092
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-703047
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37291817
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66184477
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5099768
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11300828
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5049768
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11300828
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5978067
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5412540
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32981948
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
77941089
CY2022 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
2500000
CY2021 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0
CY2022 tblt Proceeds From Factor Loan Payable
ProceedsFromFactorLoanPayable
1669000
CY2021 tblt Proceeds From Factor Loan Payable
ProceedsFromFactorLoanPayable
0
CY2022 tblt Repayments Of Loan Payable
RepaymentsOfLoanPayable
-695417
CY2021 tblt Repayments Of Loan Payable
RepaymentsOfLoanPayable
0
CY2022 tblt Repayment Of Factor Loan Payable
RepaymentOfFactorLoanPayable
0
CY2021 tblt Repayment Of Factor Loan Payable
RepaymentOfFactorLoanPayable
590950
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37433598
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82762679
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4907987
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5277374
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7472224
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2194850
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2564237
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7472224
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2022 tblt Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
3424416
CY2021 tblt Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
812949
CY2022 tblt Initial Fair Value Of Lease Liability
InitialFairValueOfLeaseLiability
5140057
CY2021 tblt Initial Fair Value Of Lease Liability
InitialFairValueOfLeaseLiability
0
CY2022 tblt Initial Fair Value Of Warrants
InitialFairValueOfWarrants
37687895
CY2021 tblt Initial Fair Value Of Warrants
InitialFairValueOfWarrants
7463005
CY2020Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1-for-10 reverse stock split (the “Reverse Split”) of its issued and outstanding common stock
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1-for-150 reverse stock split (the “2022 Reverse Split”) of its issued and outstanding common stock
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145000000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-39300000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;">Use of Estimates</div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; text-indent: 0.5in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;text-indent: 0px;;display:inline;"/> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related recognition of revenue, valuation of accounts receivable, valuation of long-lived assets, going concern assumptions, warrant valuation, inventory reserve, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;"> </div></div></div>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2918869
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Advertising Expense
AdvertisingExpense
4680366
CY2021 us-gaap Advertising Expense
AdvertisingExpense
9626374
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019 tblt Percentage Of Limitations On Net Operating Loss Carryforwards Was Removed According To Cares Act
PercentageOfLimitationsOnNetOperatingLossCarryforwardsWasRemovedAccordingToCaresAct
0.80
CY2020 tblt Percentage Of Limitations On Net Operating Loss Carryforwards Was Removed According To Cares Act
PercentageOfLimitationsOnNetOperatingLossCarryforwardsWasRemovedAccordingToCaresAct
0.80
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12975850
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
283186
CY2016Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1044828
CY2016Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1034588
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
40365286
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
38432012
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7130916
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2992692
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17500383
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13341629
CY2022 us-gaap Depreciation
Depreciation
4162153
CY2021 us-gaap Depreciation
Depreciation
1839069
CY2017Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2017Q1 us-gaap Security Deposit
SecurityDeposit
29297
CY2017Q1 tblt Direct Costs Estimated Percentage
DirectCostsEstimatedPercentage
0.2254
CY2017Q1 us-gaap Lease Cost
LeaseCost
6201
CY2022 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The lease commenced on December 1, 2019 with no rent due until April 1, 2020. From April 1, 2020 through March 31, 2025, base rent will be due on the first of each month in the amount of $25,200 escalating annually on December 1 of each year to $29,480 beginning December 1, 2023. The Company paid an initial amount of $68,128 comprising the rent for April 2020
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4415859
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
959630
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3477380
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4437010
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
959630
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1271436
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1077415
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1013237
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
370172
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4691890
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
254880
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4437010
CY2022 us-gaap Payments For Rent
PaymentsForRent
1120081
CY2021 us-gaap Payments For Rent
PaymentsForRent
650605
CY2022Q4 tblt Termination Intimation Prior Written Notice
TerminationIntimationPriorWrittenNotice
P90D
CY2022Q4 tblt Termination Intimation Prior Written Notice
TerminationIntimationPriorWrittenNotice
P90D
CY2018Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
235542
CY2018Q2 tblt Loss Contingency Notice Entry Date Served By Plaintiffs
LossContingencyNoticeEntryDateServedByPlaintiffs
2018-04-17
CY2018Q2 tblt Loss Contingency Notice Entry Date Received By Defendants
LossContingencyNoticeEntryDateReceivedByDefendants
2018-04-19
CY2018Q3 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
252949
CY2022 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
160000
CY2022 us-gaap Loss Contingency Allegations
LossContingencyAllegations
In the complaint, the 2022 Plaintiff alleged a breach of the applicable 2022 Defendants’ fiduciary duties of loyalty, good faith, and due care owed to us and our shareholders, by negligently, willfully, recklessly and/or intentionally failing to perform their fiduciary duties primarily in connection with our registered direct offering of 2,500 shares of Series F preferred stock and 2,500 shares of Series G preferred stock in February 2022 and subsequent 1-for-150 reverse stock split effected in April 2022.
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-150
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4268
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4268
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
306866
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
153433
CY2021Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
130.35
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
121.5
CY2021Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36259050
CY2021Q3 tblt Percentage Of Cashfee Equal To Gross Proceeds
PercentageOfCashfeeEqualToGrossProceeds
0.07
CY2021Q3 tblt Percentage Of Management Fee Equal To Gross Proceeds
PercentageOfManagementFeeEqualToGrossProceeds
0.005
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
25000
CY2021Q3 us-gaap Legal Fees
LegalFees
50000
CY2021Q3 tblt Clearing Fees
ClearingFees
15950
CY2021Q3 tblt Description For Market Capitalization
DescriptionForMarketCapitalization
common stock (which represents 6.0% of the shares sold to investors in the offering) at an exercise price equal to 125% of the offering price in the offering, or $162.94 (the “Placement Agent Warrants”). The Placement Agent Warrants are immediately exercisable until the fifth anniversary of the commencement of sales of the offering.
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
162.94
CY2022Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
5000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2022Q1 tblt Percentage Of Cashfee Equal To Gross Proceeds
PercentageOfCashfeeEqualToGrossProceeds
0.07
CY2022Q1 tblt Percentage Of Management Fee Equal To Gross Proceeds
PercentageOfManagementFeeEqualToGrossProceeds
0.005
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4205000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
795000
CY2022Q1 tblt Initial Fair Value Of Warrants
InitialFairValueOfWarrants
2646135
tblt Warrant Issuance Costs
WarrantIssuanceCosts
275130
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4589108
CY2022Q4 tblt Warrant Issuance Costs
WarrantIssuanceCosts
453537
CY2021Q4 tblt Number Of Warrants Issued
NumberOfWarrantsIssued
133
CY2022Q4 tblt Number Of Warrants Issued
NumberOfWarrantsIssued
133
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
121.5
CY2022Q2 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
2500000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
37.65
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.9
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
7222224
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-11457628
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8581566
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3810261
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2853820
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15267889
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11435386
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698
CY2022 tblt Effective Income Tax Rate Reconciliation Change In The Fair Value Of Warrant Percentage
EffectiveIncomeTaxRateReconciliationChangeInTheFairValueOfWarrantPercentage
0.118
CY2021 tblt Effective Income Tax Rate Reconciliation Change In The Fair Value Of Warrant Percentage
EffectiveIncomeTaxRateReconciliationChangeInTheFairValueOfWarrantPercentage
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0249
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0147
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.422
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3151
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37803576
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25466331
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
961977
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
827012
CY2022Q4 tblt Deferred Tax Assets Deferred Rent
DeferredTaxAssetsDeferredRent
0
CY2021Q4 tblt Deferred Tax Assets Deferred Rent
DeferredTaxAssetsDeferredRent
-8267
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2845164
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
669382
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
457224
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40356145
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25088276
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40356145
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25088276
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
132900000
CY2022 tblt Percentage Of Valuation Allowance On Deferred Tax Assets
PercentageOfValuationAllowanceOnDeferredTaxAssets
1
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15267889
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11435386
CY2020 tblt Capitalized Contracts Costs Incurred
CapitalizedContractsCostsIncurred
853412
CY2022 tblt Revenue Recognition Reserve For Sales Returns And Allowances
RevenueRecognitionReserveForSalesReturnsAndAllowances
13000
CY2021 tblt Revenue Recognition Reserve For Sales Returns And Allowances
RevenueRecognitionReserveForSalesReturnsAndAllowances
13000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2314237

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
tblt-20221231_lab.xml Edgar Link unprocessable
tblt-20221231_pre.xml Edgar Link unprocessable
tblt-20221231_cal.xml Edgar Link unprocessable
0001575872-23-000493-index-headers.html Edgar Link pending
0001575872-23-000493-index.html Edgar Link pending
0001575872-23-000493.txt Edgar Link pending
0001575872-23-000493-xbrl.zip Edgar Link pending
cm283_ex23-1.htm Edgar Link pending
cm283_ex31-1.htm Edgar Link pending
cm283_ex31-2.htm Edgar Link pending
cm283_ex32-1.htm Edgar Link pending
cm283_ex32-2.htm Edgar Link pending
cm283_img01.jpg Edgar Link pending
cm283_img02.jpg Edgar Link pending
cm283_img03.jpg Edgar Link pending
cm283_img04.jpg Edgar Link pending
cm283_img05.jpg Edgar Link pending
cm283_img06.jpg Edgar Link pending
cm283_img07.jpg Edgar Link pending
cm283_img08.jpg Edgar Link pending
cm283_img09.jpg Edgar Link pending
cm283_img10.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tblt-20221231.htm Edgar Link pending
tblt-20221231.xsd Edgar Link pending
tblt-20221231_def.xml Edgar Link unprocessable
tblt-20221231_htm.xml Edgar Link completed